International Breast Cancer Prevention Study Launches In The USA And Canada

Researchers in Canada and the United States are embarking on a clinical trial to see if a drug which is highly effective in treating breast cancer could be used to prevent it. The five-year study, led by renowned breast cancer researcher Dr. Paul Goss, should answer the question of whether drugs called aromatase inhibitors have a role to play in disease prevention in women after they go through menopause — the time of life when three-quarters of breast cancers are diagnosed. Goss, who is conducting a number of ongoing treatment studies with this class of drugs, said the prevention trial — launched Wednesday — was 10 years in the planning.

Back to news